KalVista Pharmaceuticals, Inc.【KALV】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
3Q25 -600,900 +41.4%
2Q25 -552,400 +39.5%
1Q25 -510,200 +38.5%
4Q24 -469,700 +36.9%
3Q24 -425,100 +34.2%
2Q24 -396,000 +34.0%
1Q24 -368,400 +34.8%
4Q23 -343,100 +37.1%
3Q23 -316,800 +40.1%
2Q23 -295,500 +45.1%
1Q23 -273,200 +48.6%
4Q22 -250,200 +49.1%
3Q22 -226,100 +47.9%
2Q22 -203,600 +42.5%
1Q22 -183,900 +38.9%
4Q21 -167,836 +38.0%
3Q21 -152,880 +32.9%
2Q21 -142,832 +35.1%
1Q21 -132,406 +32.7%
4Q20 -121,592 +31.5%
3Q20 -115,008 +37.0%
2Q20 -105,717 +32.2%
1Q20 -99,814 +30.2%
4Q19 -92,476 +29.0%
3Q19 -83,950 +18.2%
2Q19 -79,994 +21.6%
1Q19 -76,690 +26.2%
4Q18 -71,660 +28.3%
3Q18 -71,003 +37.5%
2Q18 -65,769 -
1Q18 -60,784 -
4Q17 -55,855 -
3Q17 -51,653 -41.9%
3Q16 -88,963 +32.9%
2Q16 -86,577 +39.7%
1Q16 -79,228 +49.6%
4Q15 -72,621 -
3Q15 -66,962 -
2Q15 -61,971 -
1Q15 -52,959 -